Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $4.61 $6.39 Thursday, 9th May 2024 AFMD stock ended at $5.24. This is 0.0956% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.82% from a day low at $5.14 to a day high of $5.28.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Jan 03, 2017 $18.50 $21.50 $18.50 $21.00 21 717
Dec 30, 2016 $18.00 $18.50 $18.00 $18.00 11 912
Dec 29, 2016 $18.50 $19.00 $18.00 $18.20 6 637
Dec 28, 2016 $18.50 $19.00 $18.00 $18.00 10 291
Dec 27, 2016 $18.50 $19.00 $18.00 $18.50 5 034
Dec 23, 2016 $18.00 $18.50 $16.50 $18.50 37 891
Dec 22, 2016 $18.50 $19.00 $18.00 $18.50 16 858
Dec 21, 2016 $19.00 $19.50 $18.50 $19.00 16 484
Dec 20, 2016 $20.00 $20.50 $18.50 $18.50 20 019
Dec 19, 2016 $18.50 $21.70 $18.00 $20.00 27 264
Dec 16, 2016 $18.50 $19.00 $17.50 $18.00 127 947
Dec 15, 2016 $19.50 $19.50 $18.50 $18.50 15 649
Dec 14, 2016 $20.50 $20.50 $18.50 $19.50 21 836
Dec 13, 2016 $20.50 $20.50 $20.00 $20.50 10 049
Dec 12, 2016 $20.00 $21.50 $19.50 $20.00 18 553
Dec 09, 2016 $20.00 $20.50 $20.00 $20.00 8 266
Dec 08, 2016 $20.00 $20.50 $19.00 $20.50 16 259
Dec 07, 2016 $19.50 $20.50 $19.50 $20.00 9 249
Dec 06, 2016 $22.00 $22.00 $20.00 $20.00 11 450
Dec 05, 2016 $20.00 $21.50 $19.50 $21.50 29 833
Dec 02, 2016 $20.00 $20.00 $19.50 $19.50 9 094
Dec 01, 2016 $20.50 $21.00 $19.50 $19.50 23 532
Nov 30, 2016 $20.50 $21.00 $20.00 $20.00 8 808
Nov 29, 2016 $21.50 $21.50 $20.50 $21.00 7 232
Nov 28, 2016 $23.00 $23.50 $21.50 $21.50 11 559
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT